Impact BioMedical (IBO) shares fell 8% in recent Monday trading after the company made its debut on the NYSE American Market.
The stock was trading at $2.75 in recent trading, below the IPO price of $3.
Impact BioMedical said earlier in the day it priced the IPO of 1.5 million common shares at $3 per share.
The company said it granted the underwriters a 45-day option to buy an additional 225,000 shares.
The offering is expected to close on Tuesday, the company added.
Price: 2.75, Change: -0.25, Percent Change: -8.33
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。